Michigan no-fault insurance reform : economic perspectives
|
2023 |
Dimkoff, Gregg |
Insights into social life using evolutionary basics and econ 101
|
2023 |
Cox, Donald |
Post-job loss unemployment duration for young workers
|
2023 |
Trevino, Gene A. |
The natural rate of interest, trends and pplications to forensic economics
|
2022 |
Formuzis, Peter |
Business profits as a measure of earning capacity in an accident case : fundamentals revisited
|
2022 |
Bjorklund, Paul R. |
Hedonic damages and the happiness literature : how reasonable isa constant annual value for loss of enjoyment?
|
2022 |
Jones, David D. |
A 2021 survey of forensic experts : their methods, estimates, and perspectives
|
2022 |
Garagulagian, Roman |
Changes to the Board of Editors
|
2022 |
Schap, David |
Trends in legal decisions involving hedonic damages from March 1, 2018 to July 1, 2022
|
2022 |
Ireland, Thomas R. |
Determining the reasonable value of medical care in personal injury cases and medical malpractice : a new cost-based model
|
2022 |
Wickizer, Thomas M. |
G2i, translating general population data to the individual plaintiff
|
2022 |
Slesnick, Frank |
Personal consumption and personal maintenance estimates using empirically based expenditure allocation rules
|
2022 |
Christensen, Eric W. |
An alternative measure of earning capacity for a business owner : a federal court ruling in Kaniu v. Dickerson
|
2022 |
Bjorklund, Paul R. |
Applying the mitigation principle to damages in injury lawsuits : a forensic economics perspective
|
2022 |
Bjorklund, Paul R. |
Wage net discount rates : unmasking the impact of COVID-19
|
2022 |
Baumann, Robert |
Recent decisions affecting tax neutralization in California : Clemens, Economy and Barber
|
2021 |
Ben-Zion, Barry |
The value of the value of a statistical life in the courtroom
|
2021 |
Cargill, Thomas F. |
Reply to "Comment on ‘Statistical based earnings estimates: further reflections and extension‚‚‚
|
2021 |
Sicilian, Paul |
Gamboa-Gibson worklife expectancy methods and tables : a summary of criticisms since 2009
|
2021 |
Ireland, Thomas R. |
Incorporating the costs of generic drugs in the valuation of life care plans
|
2021 |
Gaughan, Patrick A. |